Glucagon-like peptide-1 receptor agonists in patients with anthracycline related cardiac dysfunction

Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is recognized complication of antineoplastic therapies, and is particularly associated with anthracyclines. Treatment revolves around heart failure management, with limited evidence for other medications. Specifically, the aim of...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Isabel G. Scalia, Ramzi Ibrahim, Mahmoud Abdelnabi, Hoang Nhat Pham, Juan M. Farina, Milagros Pereyra Pietri, Kwan S. Lee, Balaji K. Tamarappoo, Reza Arsanjani, Chadi Ayoub
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2025-09-01
Serier:	Cardio-Oncology
Fag:	Glucagon-like peptide-1 receptor agonists Anthracycline chemotherapy Cancer therapy-related cardiac dysfunction
Online adgang:	https://doi.org/10.1186/s40959-025-00381-y
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!